The complexity of human tissue fluid precludes timely identification of cancer biomarkers by immunoassay or mass spectrometry. An increasingly attractive strategy is to primarily enrich extracellular vesicles (EVs) released from cancer cells in an accelerated manner compared to normal cells. The Vn96 peptide was herein employed to recover a subset of EVs released into the media from cellular models of breast cancer. Vn96 has affinity for heat shock proteins (HSPs) decorating the surface of EVs. Reflecting their cells of origin, cancer EVs displayed discrete differences from those of normal phenotype. GELFrEE LC/MS identified an extensive proteome from all three sources of EVs, the vast majority having been previously reported in the ExoCarta database. Pathway analysis of the Vn96-affinity proteome unequivocally distinguished EVs from tumorigenic cell lines (SKBR3 and MCF-7) relative to a non-tumorigenic source (MCF-10a), particularly with regard to altered metabolic enzymes, signaling, and chaperone proteins. The protein data sets provide valuable information from material shed by cultured cells. It is probable that a vast amount of biomarker identities may be collected from established and primary cell cultures using the approaches described here.
Introduction
According to the American Cancer Society, breast cancer remains the most commonly diagnosed cancer among women in the United States, predicting over 250,000 new cases in 2017 and accounting for 30% of all new cancer diagnoses [1] . Breast cancer further ranks second, behind lung cancer, in terms of cancer cell death among women with >40,000 incidences in 2017. While five-year breast cancer survival rates approach 100% in the case of localized tumors (stage 0 or I), the prognosis for metastasized (stage IV) breast cancer is poor, with only 22% survival at 5 years [2] . Early detection of breast cancer patients is thus crucial to improving recurrence-free survival and quality of life. Markers that distinguish invasive breast cancer phenotypes are urgently required.
Conventional screening tools, such as self-examination, mammography, diagnostic imaging (ultrasound, MRI), genetic screens (e.g., BRCA1), and tissue biopsies [3, 4] , collectively present vital tools for breast cancer detection. As with all tests, limits in sensitivity and specificity will miss some cancers (false-negatives); in other cases, abnormal findings associated with benign disease (false positives) will direct between 55% and 75% of women into unnecessary and potentially toxic chemotherapy [5] [6] [7] . The next generation of diagnostic and prognostic tests is continuously being per mL (Sigma). Remaining cells in the media were cleared by centrifugation (1000g, 10 min) and microparticulate matter was further removed by centrifugation (17,000g, 5 min), followed by syringe filtration through a 0.22 µm membrane. Filtered solutions were stored at 4 • C.
Ultracentrifugation and Sucrose Density Gradient Fractionation
The filtered SKBR3 cellular media was subject to 45 min ultracentrifugation (200,000g, 4 • C). The pellet was resuspended in 100 µL PBS, and overlaid onto a sucrose gradient (0.2-2.5 M), then spun for an additional 1 h (100,000g). A total of 11 fractions were harvested, and the refractive index was determined. Each density fraction was split in two equal portions of 250 µL, with one subject to Vn96 affinity pull-down while the other served as a control.
Vn96 Affinity Capture of EVs
Peptide Vn96 (New England Peptide, Gardener, MA, USA) was used to precipitate vesicular material from the sucrose density fractions (Section 2.2), or from 1.9 mL of the microparticle-free breast cancer cell media by adding 2.5 µL (or 10 µL for the cell culture media) of a 10 µg/µL stock solution prepared in Extraction Buffer I of the subcellular proteome extraction kit (S-PEK, Millipore Sigma), and also containing 0.04% sodium azide. The solution was briefly vortexed, and incubated overnight at 4 • C. Complexed material was pelleted by centrifugation (3000g, 5 min, room temperature). The supernatant was removed, and the pelleted material was subject to two washes with 1.9 mL PBS with 10 µL protease inhibitor, followed by centrifugation as above. The washed pelleted complex was visible as a translucent straw-yellow residue.
EV Purity by Immunobloting and Transmission Electron Microscopy
Vn96-captured EVs were resuspended by vortex in SDS-PAGE sample buffer and heating at 95 • C for 5 min. Twenty microliter volumes were resolved on BioRad Criterion gels using XT-MES or XT-MOPS electrophoresis running buffers (BioRad, Hercules, CA, USA). Resolved proteins were transferred to either supported nitrocellulose (BioRad) or PVDF (Millipore) using standard procedures. Total protein on blots was visualized with reversible stain using either the MemCode kit (PIERCE) for nitrocellulose, or Red Alert Ponceau S (EMD Chemicals Gibbstown NJ). Membranes were blocked in PBS containing 5% skimmed milk and 0.1% Tween-20 for 1 h, then incubated overnight at 4 • C in primary antibody solutions (1:1000 dilution, prepared in blocking buffer with exception of 3% milk powder). Four 10 min washes followed (blocking buffer without milk powder), then the blot was incubated for 30 min at room temperature in secondary antibody (1:2000 dilution, HRP-labelled antibody to the Ig consistent with primary antibody). All antibodies were obtained from Santa Cruz Biotechnology. HRP signal was produced using SuperSignal West Dura substrate (Pierce). The chemiluminescent image was captured using the ChemiGenius system (Syngene, Cambridge, UK).
For transmission electron microscopy, Vn96-captured EVs were prepared by fixation in aldehydes and osmium tetroxide [21] . The fixed pellet was embedded in epoxy resin and prepared as 50 µm sections. The sections were processed and examined by standard transmission electron microscopy.
Proteome Analysis
The Vn96 pellet was resuspended in 250 µL of SDS-PAGE sample buffer, supplemented to a final concentration of 4 M urea and 25 mM TCEP reducing agent (Pierce). Following heating (95 • C, 10 min), 150 µL suspended protein solutions were respectively loaded onto each of three GELFrEE cartridges (8%, 10%, and 12% Tris Acetate, Expedeon, San Diego, CA, USA) and resolved according to the manufacturer's operating guidelines. With each run, 12 fractions were collected as 150 µL aliquots. Together with non-fractionated Vn96 proteome pellets, a 7 µL portion of each collected GELFrEE fraction was subject to SDS-PAGE and silver staining, for visualization of mass-based separation and recovery per fraction.
Bottom up proteomic analysis of the GELFrEE-fractionated proteome first proceeded via SDS removal through chloroform-methanol-water precipitation, as described previously [25] . The resulting protein pellet was resolubilized in 20 µL of 8 M urea, then diluted to a final volume of 100 µL in 50 mM Tris buffer (pH 8). Proteins were reduced following addition of 5 µL of 200 mM DTT (30 min, 55 • C), then alkylated by adding 10 µL 200 mM iodoacetamide (30 min, room temperature, dark). Proteins were digested overnight at 37 • C following addition of 1 µg trypsin per fraction, and the reaction was terminated with 10 µL of 10% TFA.
Mass spectrometry was on an LTQ classic linear ion trap (ThermoFisher, San Jose, CA, USA), coupled to an Agilent 1200 HPLC system. Digested protein fractions were desalted by offline reversed phase HPLC with UV detection [26] , loading one-third of the total volume of purified protein onto a 75 µm × 30 cm self-packed C12 column (3 µm Jupiter beads, Phenomenex, Torrance, CA, USA). Peptides were separated using a 1 h linear solvent gradient from 5% acetonitrile/water/0.1% formic acid to 35% acetonitrile/water/0.1% formic acid at flow rate of 0.25 µL/min. The LTQ operated in data dependent mode (MS followed by zoom scan and tandem MS of the top three ions), with 30 s dynamic exclusion over a mass range covering the full isotopic distribution of the peptide.
Peptide identification used the Thermo Proteome Discoverer (v. 1.3, ThermoFisher, Mississauga, Canada) software package and the SEQUEST searching algorithm. MS spectra were searched against the human UniProt database, at a mass tolerance of 1 Da, allowing static cysteine carbamidomethylation and dynamic oxidation of methionine, and up to two missed cleavages per peptide. A peptide false discovery rate of 1% by decoy database searching, and minimum of one unique peptide per protein were employed for data filtering. Relative protein abundance was obtained via spectral counting [27] with normalized peptide spectral matches (PSMs), obtained by way of a ratio of the total number of PSMs observed in the SKBR3 cell line (highest PSM total) to that of the total PSMs from the given cell line. Functional annotation was performed by Ingenuity Pathway Analysis (QIAGEN Bioinformatics, Redwood City, CA, USA).
Results and Discussion
We report a comparative proteome investigation on an in vitro model of breast cancer, examining the extracellular media from SKBR-3 (invasive cancerous cell), MCF-7 (non-invasive), and MCF-10a (immortal but non-cancerous cells). While cells adapted to grow in plastic flasks are regarded as very different from those obtained in vivo, material secreted by cancer cells into the external environment in vitro is likely to produce a similar proteomic profile, reflecting the original growth from which it was derived [28] . The Vn96 peptide was employed to selectively capture EV material released by cultured cell lines into their growth media. Vn96 targets heat shock proteins (HSPs), overexpressed on the surface of aggressive cancer cells, and by extension, their derivative vesicles [29] . The Vn96 peptide has been shown to capture exosome-like vesicles containing proteins comparable to EV preparations by traditional ultracentrifugation when analyzed by Western blot [21] .
To demonstrate the specificity of Vn96 to pellet EV material, exosomes from SKBR3 were harvested through conventional ultracentrifugation with separation into characteristic flotation zones by sucrose density fractionation. As shown in Figure 1 , the exosomal marker proteins TSG101 and Alix were isolated in the fractions from 1.15 to 1.23 g/mL. Moreover, while these marker proteins remain suspended in the supernatant (SN) following low speed centrifugation, the addition of Vn96 resulted in recovery of exosomal markers in the pellet (P) of the low speed spin. These observations demonstrate the capacity of Vn96 to concentrate proteins associated with vesicular material. The Vn96 peptide was next employed to directly recover EV materials from filtered bioreactor cell culture media. When observed by TEM Figure 2 , material pulled down by Vn96 generally consisted of bilayer orb structures between 30 and 50 nm in diameter, with electron dense centers. Such features were also evident in the MCF-10a cell line, indicative that HSP-decorated vesicles are also released by these cells. In recent years, the term "small EVs" has been used as an alternative to exosomes [30] . Vn96 may capture a subset of small EVs, as defined by surface accessorization of HSPs. Electrophoretic profiling of Vn96 pull-downs yielded robust total protein profiles (e.g., from SKBR3, Figure 3A lane 1) . Replacement of Vn96 with a random peptide (SW) yielded faint profiles likely to be aggregates of albumin and immunoglobulin from culture medium ( Figure 3A, lane 2) . The heat shock proteins (HSP70, HSP90) targeted by Vn96 were depleted from the medium and exclusively recovered in the low centrifuge speed pellet. Employing a random peptide (SW), or scrambled amino acid sequence of Vn96 did not pellet these proteins ( Figure 3B ). Western blots of EV material also identified PKM2, receptor kinase HER2, membrane protein TRPV6, and fatty acid synthase; none of which were recovered using the null peptide ( Figure 3B ). The stability of EVs isolated by Vn96 from SKBR3 is also evident in Figure 3C , which employs various commercial detergent washes (components of Millipore's subcellular proteome extraction kit, S-PEK). As seen in lanes 1 and 2 of Figure 3C , neither cytosolic Extraction Buffer I (EB1), which contains the mild detergent digitonin, nor membrane and organelle Extraction Buffer II (EB2), containing Triton X-100, would solubilize the EV marker proteins from the Vn96 pellet. Similar results are obtained from the other cell lines. Though EV marker proteins are retained following EB1 and EB2 washes, weakly associated proteins are liberated from the EV pellet by these buffers (see Supplementary Figure S1 ). These findings permit incorporation of stringent washes to further purify the EV fraction recovered in the Vn96 pellet. Immunoblot analysis on material recovered from the non-transformed MCF-10a The Vn96 peptide was next employed to directly recover EV materials from filtered bioreactor cell culture media. When observed by TEM Figure 2 , material pulled down by Vn96 generally consisted of bilayer orb structures between 30 and 50 nm in diameter, with electron dense centers. Such features were also evident in the MCF-10a cell line, indicative that HSP-decorated vesicles are also released by these cells. In recent years, the term "small EVs" has been used as an alternative to exosomes [30] . Vn96 may capture a subset of small EVs, as defined by surface accessorization of HSPs. The Vn96 peptide was next employed to directly recover EV materials from filtered bioreactor cell culture media. When observed by TEM Figure 2 , material pulled down by Vn96 generally consisted of bilayer orb structures between 30 and 50 nm in diameter, with electron dense centers. Such features were also evident in the MCF-10a cell line, indicative that HSP-decorated vesicles are also released by these cells. In recent years, the term "small EVs" has been used as an alternative to exosomes [30] . Vn96 may capture a subset of small EVs, as defined by surface accessorization of HSPs. Electrophoretic profiling of Vn96 pull-downs yielded robust total protein profiles (e.g., from SKBR3, Figure 3A lane 1). Replacement of Vn96 with a random peptide (SW) yielded faint profiles likely to be aggregates of albumin and immunoglobulin from culture medium ( Figure 3A , lane 2). The heat shock proteins (HSP70, HSP90) targeted by Vn96 were depleted from the medium and exclusively recovered in the low centrifuge speed pellet. Employing a random peptide (SW), or scrambled amino acid sequence of Vn96 did not pellet these proteins ( Figure 3B ). Western blots of EV material also identified PKM2, receptor kinase HER2, membrane protein TRPV6, and fatty acid synthase; none of which were recovered using the null peptide ( Figure 3B ). The stability of EVs isolated by Vn96 from SKBR3 is also evident in Figure 3C , which employs various commercial detergent washes (components of Millipore's subcellular proteome extraction kit, S-PEK). As seen in lanes 1 and 2 of Figure 3C , neither cytosolic Extraction Buffer I (EB1), which contains the mild detergent digitonin, nor membrane and organelle Extraction Buffer II (EB2), containing Triton X-100, would solubilize the EV marker proteins from the Vn96 pellet. Similar results are obtained from the other cell lines. Though EV marker proteins are retained following EB1 and EB2 washes, weakly associated proteins are liberated from the EV pellet by these buffers (see Supplementary Figure S1 ). These findings permit incorporation of stringent washes to further purify the EV fraction recovered in the Vn96 pellet. Immunoblot analysis on material recovered from the non-transformed MCF-10a Electrophoretic profiling of Vn96 pull-downs yielded robust total protein profiles (e.g., from SKBR3, Figure 3A lane 1) . Replacement of Vn96 with a random peptide (SW) yielded faint profiles likely to be aggregates of albumin and immunoglobulin from culture medium ( Figure 3A , lane 2). The heat shock proteins (HSP70, HSP90) targeted by Vn96 were depleted from the medium and exclusively recovered in the low centrifuge speed pellet. Employing a random peptide (SW), or scrambled amino acid sequence of Vn96 did not pellet these proteins ( Figure 3B ). Western blots of EV material also identified PKM2, receptor kinase HER2, membrane protein TRPV6, and fatty acid synthase; none of which were recovered using the null peptide ( Figure 3B ). The stability of EVs isolated by Vn96 from SKBR3 is also evident in Figure 3C , which employs various commercial detergent washes (components of Millipore's subcellular proteome extraction kit, S-PEK). As seen in lanes 1 and 2 of Figure 3C , neither cytosolic Extraction Buffer I (EB1), which contains the mild detergent digitonin, nor membrane and organelle Extraction Buffer II (EB2), containing Triton X-100, would solubilize the EV marker proteins from the Vn96 pellet. Similar results are obtained from the other cell lines. Though EV marker proteins are retained following EB1 and EB2 washes, weakly associated proteins are liberated from the EV pellet by these buffers (see Supplementary Figure S1 ). These findings permit incorporation of stringent washes to further purify the EV fraction recovered in the Vn96 pellet. Immunoblot analysis on material recovered from the non-transformed MCF-10a cell culture media, as well as for MCF-7, with the breast cancer exosomal marker CD24 [31] , illustrate that some, but not all, CD24 is released into the supernatant following incubation of the pellet with EB II (results not shown). Thus, we subsequently chose a PBS washing protocol, also under reducing conditions (25 mM TCEP), to achieve a balance of yield and purity. To fully solubilize EV proteins (lane 3 of Figure 3C ), the pellet is boiled in SDS gel-loading buffer, supplemented with 4 M urea (USB). As a consequence, MS analysis demands an SDS-compatible proteomics workflow.
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Mass spectrometry detection followed GELFrEE fractionation of the solubilized EV proteomes. GELFrEE enables recovery of proteins in an SDS-containing buffer, with separation according to molecular weight. SDS depletion via organic solvent precipitation permits LC/MS of trypsin-digested proteins. As demonstrated in Figure 4A , a higher abundance of EV proteins was recovered from the SKBR3 and MCF-7 cell lines, relative to the non-cancerous MCF-10a, in support of the theory that aggressive cancer cells will overexpress EV materials. The decreased abundance of proteins recovered by Vn96 from the MCF-10a cell media may also reflect a lower number of Vn96 binding opportunities, due to lack of surface expressed HSP/chaperones. Nonetheless, it is clear that a greater concentration of proteins is recovered from the tumorigenic cell lines. GELFrEE resolved the proteins over a mass range extending to ~100 kDa Figure 4B , isolating proteins in discrete fractions according to molecular weight ( Figure 4C) . A detailed listing of the identified proteins and peptides from each of the three cell lines are provided as supplementary files (Tables S1-S3 ). will not release proteins from the Vn96 pellet, permitting incorporation of a wash step to improve purity. As controls, equivalent volumes of culture medium were processed by ultracentrifugation (UCF), the pellet was resuspended in electrophoresis buffer and loaded directly (Lane 11).
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Considering the full list of proteins collectively identified in the EV material, a broad range of biological function is conveyed (Supplementary Figure S2) . The largest group of proteins identified (18%) were associated with metabolic activity. The chaperone/binding proteins were also prominent among the identified groups. A preliminary comparison of the molecular pathways associated with the identified proteins is seen through Ingenuity Pathway Analysis (IPA), for which the top 12 pathways of each cell type are depicted in Supplementary Figure S3 . The most distinguishing feature was the glycolysis/gluconeogenesis and the pentose phosphate pathways, represented at the top of IPA pathways represented in SKBR3 (second and fourth for MCF-7). By sharp contrast, metabolic enzymes constitutive of these pathways were essentially absent from MCF-10a.
Cancers are dominated by metabolic pathways that vary from normative physiology with emphasis on accelerated uptake of glucose and glutamine, aerobic glycolysis, decreased mitochondrial activity, and enhanced lipogenesis. Table 4 provides a quantitative comparison of proteins involved in metabolic pathways. Perhaps the most well-known characteristic, the Warburg effect [35] , refers to the avid consumption of glucose for direction into a glycolytic pathway with the accumulation of lactate, rather than incorporation of pyruvate into the tricarboxylic acid (TCA) cycle for oxidative phosphorylation. Nine of the ten canonical enzymes of glycolysis were represented in the Vn96 captured EVs of both SKBR3 and MCF-7, though only five were observed in MCF-10a. Some elements were exclusively found in the invasive and non-invasive VNEs, such as isoforms of pyruvate kinase and lactate dehydrogenase. Lactate dehydrogenase is perhaps the most widely recognized secreted enzyme of glycolysis contributing to the acidification paradigm of the Warburg effect [36] . Metabolism is thus closely linked to cancer progression, because the ability for a cell to proliferate is dependent upon the availability of nutrients to build new cells. Glycolytic enzymes also protect cancer cells from stress by inhibiting apoptosis, and correlate well with resistance to radio-and chemotherapy [37, 38] . Early diversions are promoted toward the pentose phosphate pathway as the means to generate nucleotide and amino acids. Of relevance was the detection of phosphogluconate dehydrogenase in higher abundance for the cancerous cell lines. Beyond glycolysis, the provision of raw materials into peripheral biosynthetic pathways is crucial to cancer survival and colonization of areas distal to the primary tumor [39] . For example, glycolysis channels raw material into lipid biosynthesis for membrane expansion and vesicle production [40, 41] . Lipogenesis, required for membrane expansion and vesicle production, and typical of the aggressive cancer, would benefit from the donation of precursors. As seen in Table 4 , a high proportion of peptides originate from fatty acid synthase (FASN) in the invasive SKBR3. Similarly, tumor protein D52 was also exclusively observed in SKBR3, being implicated in increased capacity for storing lipid typical of invasive cancer cells [42] . The significance of FASN abundance in an invasive phenotype is likely associated with the promotion of membrane biogenesis. FASN is frequently associated with invasive cancer, and has been proposed as a therapeutic target [43] . It is normally expressed in low levels when dietary sources are sufficient. However, FASN expression and activity in cancer cells can be very high, and becomes associated with lipid rafts following cell signaling events [44] . Serum levels of FASN have been found extracellularly in breast cancer [45] , and are predictive of colorectal cancer stage [46] . FASN has previously been found in exosomes from multiple cancer cells [32] . Accordingly, it is possible that proportional representation of FASN in exosomes is a prospective biomarker of invasive phenotype [47] .
As ligands for the Vn96 affinity peptide, individual canonical heat shock proteins are listed in Table 5 . HSP60 was the most abundantly represented heat shock protein among the three cell lines, and most highly expressed in SKBR3. HSP60 is a known surface-displayed molecule, secreted by cancer cells, and an important marker of cancer-derived exosomes [48] . Isoforms of HSP90 were more extensively represented in SKBR3, though also observed in the non-cancerous cell line MCF7. HSP90-alpha constitutes the extracellular isoform, and is particularly characteristic of invasive cancer [49] . Although location of HSP90 isoforms was not determined, this family of proteins is frequently found on the cell surface of cancer cells, and by extension, on derivative vesicles [50] . HSP90 is imperative as a stabilizing chaperone of a broad range of aberrantly overactive receptors and kinases imperative to cancer. Transient HSP-multi protein complexes, coined as the "epichaperome" and found in high prevalence on numerous cancers, have been shown to play important roles in facilitating cell regulation and survival [51] . Thus, while smaller chaperones, HSP10 or HSP27, were observed in higher abundance in the cancerous cell lines, it is unknown if these are independently capable of engaging Vn96. However, HSP10 and 27 have been implicated in multifunctional chaperone networks in invasive breast cancer [52] . HSP chaperone complexes not only present biomarkers for cancer diagnostics, but have been identified as targets for drug therapy [51] . The functional elements of a metastatic cascade reside in secreted proteins invested in HSP-decorated EVs. Cumulatively, these proteins enable cells to detach, invade tissue, and access circulation, while buffering against toxicity. Proteome profiling of the EV materials from malignant vs non-invasive phenotypes reveals multiple features conducive to malignancy, some of which have only been appreciated in the last year. A short selection is provided in Table 6 . The role of these proteins in cancer progression is described in the table with reference to literature. For example, protein disulfide isomerases are multifunctional chaperones instrumental in the breakage and rearrangement of disulfide bonds of extracellular matrix proteins, being required for detachment, extravasation, and intravasation at secondary sites, particularly with regard to cellular matrix remodeling. Other proteins may protect or preserve aspects crucial to metabolism (e.g., selenium-binding protein 1), while other proteins may promote expression of specific proteins or enable function to maintain the malignant phenotype (14-3-3 zeta). The Vn96 protocol to isolate EV materials uncovers multiple distinguishing protein features, which collectively constitute candidate biomarkers of breast cancer. Previous investigations on breast cancer cell lines [66] , or of their secreted exosomes [67] , have highlighted proteomic profiles indicative of cancer cell proliferation and mobility, which was also apparent from our study. Our observations also corroborate a proteomic study that identified proteins involved in metabolic and detoxification pathways as highly expressed in HER-2/neu-positive breast cancer [68] .
Conclusions
Vesicles were recovered from extracellular media by peptides with affinity to heat shock proteins, which are abundant on cancer cell surface and derivative vesicles or exosomes. Extracellular vesicles (EVs) were subject to GELFrEE fractionation and proteome analysis via bottom up liquid chromatography mass spectrometry (LC/MS). Enzymes typical of altered metabolic pathways were abundantly represented in EVs from cancer cells. Vesicle-associated proteins from the most invasive phenotype, SKBR3, included most of the canonical enzymes of glycolysis and gluconeogenesis. In contrast, the same proteins were of limited representation or absent in EVs from non-transformed MCF-10a, while MCF-7 yielded an intermediate representation. These observations indicate that the collection of extracellular vesicles from different cancer cell phenotypes may provide insight into the importance of individual enzymes in cancer progression, and further, that the vesicles shed from cancer cells serve as surrogates for profiling abundance of altered metabolic enzymes.
